Fundamental Research Corp.’s Post

CEO Robert Clarke discusses #biotech exit strategy and the importance of considering the perspectives of different audiences – from current investors to future investors and potential partners.   Check out “March Madness – Biotech Style” on LifeSciVC's From the Trenches blog: bit.ly/3CNGtL6

Should I include so-called ‘bolus patients’ in my asset’s valuation? It depends on the objective. Considerations that need to be addressed span the level of detail needed which is typically linked to the development phase of the asset, potential investment decisions, supply decisions, and treatment practices. For a broader discussion on this topic and other crystal ball exercises, check out the Solutions page of our website. https://lnkd.in/eK2gMv3r #biotech #strategy #insight

Uncover investment opportunities in potential winners with the Next Edge Biotech and Life Sciences Opportunities Fund. With a unique investment approach, we offer exclusive access to small and midcap companies poised for growth. Click here and learn more about The Next Edge Biotech and Life Sciences Opportunities Fund: https://lnkd.in/eEsJKHt #AlternativeInvestments #NextEdgeCapital #Biotech #LifeSciences Eden Rahim Evie Dargel Braydon Evans Karl Bruce Janine Breck Richard Goode

View the key highlights from our latest commentary on Next Edge Biotech and Life Sciences Opportunities Fund below. To access the full text and marketing materials, please click the link: https://lnkd.in/efRA_uy #biotech #investment #alternativeinvestments

1 week until we hit Whistler, BC for the BIOTECanada Investor Summit! Ready to connect with industry leaders and discuss what's next for us in the world of biotech. #BIOTECanada

Phil Newman, CEO & Founder of Longevity.Technology, a digital investment platform for international investors and longevity start-ups, sits down at the LBA roundtable with Nir Barzilai for a presentation on investing in longevity biotechnology. Link to the discussion is in the comments. #LongevityInvesting #BiotechInvesting #TechTalk #LBARoundtable

Fresh statistics on Top100 Investors in Biotech is in. #biotech #investing #vcfunding

🔴 The latest UK #Biotech financing 2024 Q1 and Q2 report is out now ➡️ https://lnkd.in/e94GgQWd According recent data, £564 million VC funding was raised by #UK #Biotechs in Q2, that is an increase of 135% 📈 Despite global uncertainty, investment in the UK innovative #LifeScience and biotech industry continue to show strong growth 👏 What does this mean for the sector moving forward? Find out in the link above ⬆️ #InvestInBiotech

Did you know, that more than 2 Billion Euros is secured in investments within the Biotech & Life Science industry on Funen? 🔬 If you want more exciting numbers and facts from the Biotech & Life Science industry, make sure to subscribe to our newsletter and download the latest insight report on the flourishing biotech and life science industry 👇 https://lnkd.in/eeTy6sNV #biotech #lifescience #investments #investinodense #cityofodense

Windlas Biotech Share Analysis I Windlas Biotech Share Latest News | Breakout Share Today 🚀 Embark on a journey of discovery with our latest video, as we delve into the intricate world of Windlas Biotech's share chart patterns, unlocking the hidden potential for a breakthrough in your investment strategy! 📈 In this comprehensive analysis, we navigate through key technical indicators, chart patterns, and market dynamics to provide you with actionable insights into Windlas Biotech's imminent breakout. https://lnkd.in/gmvfZi6Y #WindlasBiotechShare #WindlasBiotechShareAnalysis #WindlasShareBreakout #WindlasBiotechShareLatestNews #WindlasBiotechShareTarget #BreakoutShare #BreakoutStrategy #BreakoutAnalysis #ChartPatterns